1.Amosova E.N., Yaremenko O.B., Matiyashchuk I.G., et al. State of the endothelium-dependent and endothelium-independent vazoregulyatsii in patients with systemic lupus erythematosus / / Ukr. revmatol. Journal. 2008. 4 (34). Р. 4–9. (In Russian)
2.Antonov V.G., Kozlov V.K. The pathogenesis of cancer: immune and biochemical phenomena and mechanisms. Extracellular and cellular mechanisms of general immunosuppression and immune resistance / / Cytokines and Inflammation. 2004. T. 3. Number 1. Pp. 8-19. (In Russian)
3.Baluda V.P., Barkagan Z.S., Goldberg E.D., et al. Laboratory methods of hemostasis / / Tomsk Univ. University Press, 1980. 314. (In Russian)
4.Berezhnaya N.M., Chekhun V.F. Interleukins system and cancer (New aspects of the interaction of the tumor and the body) / / Kiev: DIA, 2000. 224 p. (In Russian)
5.Borovikov V.P. STATISTICA: the art of analyzing data on a computer / / St. Petersburg.: Peter, 2003. 688. (In Russian)
6.Verzhbitskaya N.E., Magarill J.A. Comparative characteristics of the frequency of certain types of malignant non-Hodgkin's lymphoma in the Kemerovo region and other geographical regions / / Siberian Journal of Oncology. 2007. Number 4. Pp. 96-100. (In Russian)
7.Grebennicpva L.G. The use of occlusive test to assess endothelial function in patients with rheumatoid arthritis / / InVestRegion. 2008. Number 3. Pp. 60-64. (In Russian)
8.Davydov M.I., Aksel E.M. Malignant neoplasms in Russia and the CIS in 2006 / / Bulletin RCRC. NN RAMS. 2008. T. 19, № 2 (Suppl 1). 152. (In Russian)
9.Domashenko M.A., Orlova S.V., Kostyreva M.V., et al. Endothelial dysfunction in ischemic cerebrovascular disorders for CHD / / Heart. 2007. T. 5, № 7. Pp. 376-378. (In Russian)
10.Dorokhin K.M., Spas V.V. Pathophysiological aspects of endogenous intoxication / / Anesthesiology and Critical Care Medicine. 1994. Number 1. Pp. 56-60. (In Russian)
11.Kadagidze Z.G. Cytokines / / Practical Oncology. 2003. Volume 4, № 3. Pp. 131-139. (In Russian)
12.Kareva N.P. Clinical and pathogenetic aspects of the mechanism of action of electromagnetic radiation in the millimeter range chemotherapy complications of lymphoma: Author. dis. Dr. med. Science. Novosibirsk, 2007. 42. (In Russian)
13.Ketlinskiy S.A., Simbirtsev A.S. Cytokines. SPb.: Folio, 2008. 552 s. (In Russian)
14.ESMO Clinical Recommendations for diagnosis, treatment and monitoring with primary non-Hodgkin's lymphoma diagnosed large-/ / Minimum clinical recommendations of the European Society for Medical Oncology (ESMO). Moscow: RCRC. NN Blokhin, 2003. Pp. 25-27. (In Russian)
15.Loseva M.I., Pospelova T.I., Soldatova G.S., et al. Remote consequences of anticancer therapy Leukemia. Novosibirsk: IPP «Art-Avenue», 2005. 364 p. (In Russian)
16.Lysenko N.V. Endothelin-1 and cyclic guanosine monophosphate in the blood plasma of patients with rheumatoid arthritis associated with Raynaud's syndrome / / Ukr. revmatol. Journal. 2002. № 1 (7). Pp. 57-60. (In Russian)
17. Nebieridze D.V. Endothelial dysfunction and its correction for hypertension / / Russian Journal of Medicine. 2006. T. 14, № 2. Pp. 127-131. (In Russian)
18. Podoltseva E.I. Features of treatment of aggressive lymphomas / / Practical Oncology. 2004. T. 5, № 3. Pp. 194-202. (In Russian)
19. Shilkina N.P., Molodkina O.A., Vinogradov A.A. Changes in vascular and endothelial function in systemic vasculitis / / Scientific and practical rheumatology. 2007. Number 2. Pp. 19-23. (In Russian)
20. Aukrust P., Shardal A.M., Muller F. et al. Decreased levels of total and reduced glutathione in CD4 lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenetic role of oxidative stress // Blood. 1995. Vol. 86. P. 1383–1391.
21. Hennessy B.T., Hanraban E.O., Daly P.A. Non Hodgkin's lymphoma; an update // Lancet Oncol. 2004. Vol. 5. P. 341–353.
22. Nedeljkovic Z.S., Gokce N., Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction // Postgrad. Med. J. 2003. Vol. 79 (930). P. 195–199.
23. Schmitt M., Mengele K., Schueren E. et al. European Organi- sation for Research and Treatment of Cancer (EORTC) Pathobiology Group standard operating procedure for the preparation of human tumour tissue extracts suited for the quantitative analysis of tissue as- sociated biomarkers // Eur. J. Cancer. 2007. Vol. 43 (5). P. 835–844.
24. Szlosarek P., Kellie A.C., Balkwill F.R. Tumour necrosis factor α as a tumor promoter // Eur. J. Cancer. 2006. Vol. 42 (6). Р. 745–750.